Prestige Consumer Healthcare (PBH) Return on Capital Employed Growth (3y) (2014 - 2025)
Prestige Consumer Healthcare (PBH) Return on Capital Employed Growth (3y) (2014 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.69 Bn | 87.82 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.96 Bn | 32.22 Bn | 1.97 Bn | 1,301.00 |
| 3 | Zoetis | 32.61 Bn | 30.67 Bn | 1.62 Bn | 331.00 |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.49 Bn | 4.39 Bn | -667.00 |
| 5 | United Therapeutics | 23.06 Bn | 20.91 Bn | 648.10 Mn | 480.00 |
| 6 | RedHill Biopharma | 22.43 Bn | 22.43 Bn | - | - |
| 7 | Viatris | 20.25 Bn | 18.44 Bn | 1.16 Bn | -254.00 |
| 8 | Neurocrine Biosciences | 17.75 Bn | 16.43 Bn | 800.70 Mn | 1,342.00 |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | 1,902.00 |
| 10 | Prestige Consumer Healthcare | 2.44 Bn | 2.38 Bn | 157.37 Mn | 23.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 23.00 |
| Sep 30, 2025 | 65.00 |
| Jun 30, 2025 | 93.00 |
| Mar 31, 2025 | 96.00 |
| Dec 31, 2024 | 111.00 |
| Sep 30, 2024 | 109.00 |
| Jun 30, 2024 | 113.00 |
| Mar 31, 2024 | 172.00 |
| Dec 31, 2023 | -968.00 |
| Sep 30, 2023 | -981.00 |
| Jun 30, 2023 | -971.00 |
| Mar 31, 2023 | -938.00 |
| Dec 31, 2022 | 753.00 |
| Sep 30, 2022 | 744.00 |
| Jun 30, 2022 | 724.00 |
| Mar 31, 2022 | 740.00 |
| Dec 31, 2021 | 359.00 |
| Sep 30, 2021 | 337.00 |
| Jun 30, 2021 | 339.00 |
| Mar 31, 2021 | 313.00 |